According to our (Global Info Research) latest study, the global Immune Cell Bank Storage Services market size was valued at US$ 1071 million in 2025 and is forecast to a readjusted size of US$ 1866 million by 2032 with a CAGR of 8.3% during review period.
Immune Cell Bank Storage Services refer to integrated services provided by specialized cell banks, biotechnology companies, and healthcare organizations for the collection, isolation, testing, processing, cryopreservation, quality management, long-term storage, and subsequent retrieval of immune cells. These services are primarily intended to preserve autologous immune cell resources for potential future applications in cell therapy, personalized medicine, clinical research, and health management, providing high-quality biological starting material for possible cell expansion, functional modification, or other advanced therapeutic applications.
The growth of the Immune Cell Bank Storage Services market is primarily driven by the continued development of cell therapy and precision medicine, increasing awareness of personalized health management, and the expanding potential applications of immune cells in clinical medicine. Rapid progress in CAR-T, TCR-T, NK cell therapies, and other immune-cell-based approaches has increased the strategic value of immune cells as biological resources for oncology, immune modulation, and regenerative medicine research, encouraging both individuals and healthcare institutions to place greater emphasis on the long-term preservation of high-quality cell samples. At the same time, population aging, the growing burden of chronic diseases, and rising demand for preventive and personalized healthcare among higher-income consumers are creating additional opportunities for commercial immune cell banking. Advances in cell isolation, controlled-rate freezing, automated cryogenic storage, sample traceability, and digital biobank management are also improving storage safety, standardization, and operational efficiency. As clinical research in cell therapy expands and regulatory and quality frameworks continue to evolve, demand for professional and standardized immune cell banking and storage services is expected to increase steadily.
Report Scope
This report is a detailed and comprehensive analysis for global Immune Cell Bank Storage Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immune Cell Bank Storage Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Immune Cell Bank Storage Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Immune Cell Bank Storage Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Immune Cell Bank Storage Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Cell Bank Storage Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Cell Bank Storage Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Cell Therapy Group, Boyalife, Vcanbio, Health & Biotech, HealthBanks, Origincell, Shenzhen Beike Bio-Technology, CryoCord, Sino Biotech, Qilu Cell Therapy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Immune Cell Bank Storage Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
Natural Killer Cell Banking
T-Cell Banking
Others
Market segment by Storage Period
Short-term Storage
Medium-term Storage
Long-term Personal Storage
Market segment by Application
Personal
Clinical
Others
Market segment by players, this report covers
Shanghai Cell Therapy Group
Boyalife
Vcanbio
Health & Biotech
HealthBanks
Origincell
Shenzhen Beike Bio-Technology
CryoCord
Sino Biotech
Qilu Cell Therapy
Haier International Cell Bank
Guangdong Saier Biotechnology
Yuanpin Cell Biotechnology Group
CytoMed Therapeutics
Bioscience Institute
CellEntrust
Immunaeon
Guangzhou SALIAI Stemcell
S-Evans Biosciences
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Immune Cell Bank Storage Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immune Cell Bank Storage Services, with revenue, gross margin, and global market share of Immune Cell Bank Storage Services from 2021 to 2026.
Chapter 3, the Immune Cell Bank Storage Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Immune Cell Bank Storage Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Cell Bank Storage Services.
Chapter 13, to describe Immune Cell Bank Storage Services research findings and conclusion.
Summary:
Get latest Market Research Reports on Immune Cell Bank Storage Services. Industry analysis & Market Report on Immune Cell Bank Storage Services is a syndicated market report, published as Global Immune Cell Bank Storage Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Immune Cell Bank Storage Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.